Moreover, it has been shown that introducing genetic changes to CD34+ human hematopoietic progenitor cells before injecting these cells into immunodeficient mice could generate a humanized mouse leukemic model that has recapitulating features of primary leukemia [40]. This evidence concerns the gene CD34 and leukemia.